IHC predominantly showed weak or negative staining for markers such as TTF‐1, CK5/6, p40, synaptophysin, chromogranin A, and CD56, which are often associated with adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors. Here, NCAM1 is linked to neuroendocrine neoplasm.